Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Dacryocystitis - osteopoikilosis is an exceedingly rare autosomal dominant disorder reported in only a few patients to date and is characterized by dacryocystitis due to lacrimal canal stenosis,and osteopoikilosis (demonastratedr adiologically as discrete spherical osteosclerotic lesions of 2-10mm in diameter).
Features include: Osteopoikilosis and Dacryocystitis.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Bones and joints | 1 | Osteopoikilosis |
Biomarker and diagnostic research for dacryocystitis-osteopoikilosis syndrome has been reported in the published literature.
No clinical trials have been registered for dacryocystitis-osteopoikilosis syndrome.
145 publications have been identified in PubMed for dacryocystitis-osteopoikilosis syndrome. Research spans Review / Meta-Analysis (65%), Basic Science / Preclinical (14%), and Case Report / Case Series (8%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 94 | 65% |
Data assembled from 5 of 12 sources · Last updated Sep 19, 2026, 9:41 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center
Laboratory research
20 |
14% |
Patient case studies | 12 | 8% |
Disease patterns and progression | 9 | 6% |
Other research | 6 | 4% |
Testing and diagnosis research | 2 | 1% |
Clinical study results | 1 | 1% |
New treatment approaches | 1 | 1% |
Aguilar AA (2026). [PMID: 41758717](https://pubmed.ncbi.nlm.nih.gov/41758717/). *AACN Adv Crit Care*. [Review / Meta-Analysis]
Lee S (2026). [PMID: 41206258](https://pubmed.ncbi.nlm.nih.gov/41206258/). *Am J Geriatr Psychiatry*. [Review / Meta-Analysis]
Amado C (2026). [PMID: 40975490](https://pubmed.ncbi.nlm.nih.gov/40975490/). *Ann Allergy Asthma Immunol*. [Review / Meta-Analysis]
Anderson EN (2026). [PMID: 41468891](https://pubmed.ncbi.nlm.nih.gov/41468891/). *Am J Hum Genet*. [Basic Science / Preclinical]
Avelino-Silva TJ (2026). [PMID: 41591773](https://pubmed.ncbi.nlm.nih.gov/41591773/). *JAMA Netw Open*. [Epidemiology / Natural History]
Papazachariou A (2026). [PMID: 41128447](https://pubmed.ncbi.nlm.nih.gov/41128447/). *Curr Opin Clin Nutr Metab Care*. [Review / Meta-Analysis]
Manto M (2026). [PMID: 41663552](https://pubmed.ncbi.nlm.nih.gov/41663552/). *J Neurol*. [Other]
Asghar E (2026). [PMID: 41401403](https://pubmed.ncbi.nlm.nih.gov/41401403/). *Ocul Immunol Inflamm*. [Review / Meta-Analysis]
Gobble MRS (2025). [PMID: 40128490](https://pubmed.ncbi.nlm.nih.gov/40128490/). *Curr Diab Rep*. [Review / Meta-Analysis]
Patel NM (2025). [PMID: 41101800](https://pubmed.ncbi.nlm.nih.gov/41101800/). *Facial Plast Surg Clin North Am*. [Review / Meta-Analysis]